On Cancer

and/or

98 Blog posts found

Feature

The Art of Listening: Using Patient Feedback to Improve Cancer Care

Why asking our patients how they’re doing, and listening to what they have to say, teaches us how to care for them.

Vincent Laudone, Chief of Surgery at the Josie Robertson Surgery Center

In the Lab

Why Do Immune Checkpoint Inhibitors Work for Only Some People with Cancer?

Learn about why checkpoint inhibitors, a class of immunotherapy drugs, 
is paying off — but only for some patients.

MSK physician­scientist Luis Diaz

In the Lab

Stem Cell Research Probes Why a Breast Cancer Treatment Sometimes Damages the Heart

Investigators are looking at how and why the breast cancer drug trastuzumab sometimes causes long-lasting and potentially serious cardiac side effects.

Stem cells induced to become cardiomyocytes

In the Clinic

Reduced Radiation Dose for Neuroblastoma Could Spare Children from Complications Later

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.

Smiling female physician, sitting on right, holding stethoscope against abdomen of blond girl

In the Clinic

Low-Dose Radiation a Possible “Game Changer” for Treating HPV-Positive Throat Cancer

An MSK study has shown that HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects.

Female physician in white coat sitting at screen that shows medical image.

In the Clinic

Light-Activated Drug Destroys Small Prostate Cancers with Fewer Side Effects

A novel treatment for prostate cancer involves a light-sensitive drug that destroys small tumors and the blood vessels that feed them.

A hand holding a thin optical fiber giving off a red light.

Finding

Immunotherapy Combination Offers a Better Chance at Longer Survival for Patients with Metastatic Kidney Cancer

Learn about how the immunotherapies ipilimumab (Yervoy®) and nivolumab (Opdivo®) could provide a new option for patients with metastatic renal cell carcinoma.

Cancer cells of the human kidney

In the Clinic

FDA Grants Breakthrough Therapy Designation to Burtomab for Metastatic Neuroblastoma

A drug created at MSK called burtomab reaches an important milestone toward becoming a treatment for metastatic neuroblastoma.

Head shot of smiling female doctor in civilian clothes with arms folded.

In the Clinic

The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.

MSK medical oncologist Luis Diaz, Jr.

In the Clinic

Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer

A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy.

Head shot of doctor with glasses, white shirt, and blue tie in his lab.